Retinitis Pigmentosa + RPGR orf15 by Massively Parallel Sequencing

Clinical Use

Use

The Retinitis Pigmentosa + RPGR orf15 Panel is developed for identifying causes related to retinitis pigmentosa (RP) and Leber congenital amaurosis (LCA), both of which are serious inherited disorders that affect vision. RP has various genetic origins, and its symptoms often emerge in early adulthood, leading to progressive vision loss and potentially legal blindness. In contrast, LCA manifests at birth and can involve developmental delays. Genetic testing is critical for confirming a diagnosis and for guiding treatment and management strategies in affected individuals, particularly those with symptomatic family histories.

Special Instructions

Testing is indicated for patients with a clinical suspicion of retinitis pigmentosa or those with a family history suggestive of it. It is important to collect samples correctly to ensure accurate results. Depending on the sample type, specific instructions for collection, shipping temperature, and handling should be followed meticulously.

Limitations

This test features massively parallel sequencing to identify potential mutations but is limited in its capacity to detect larger genomic rearrangements or deep intronic mutations. Variants identified will necessitate confirmation through Sanger sequencing to ensure accuracy and specificity. Careful interpretation of sequence data is vital, especially in cases where rare variants are involved, as these may not be fully characterized or understood at the level of clinical significance.

Test Details

New York Approved